Market Overview

Morning Market Movers

Share:
Related OMED
OncoMed Reports Presentation of Phase 1b Trial for Tarextumab in Small Cell Lung Cancer at ASCO
OncoMed Presents Data From Phase 1b Trial of Demcizumab in Pancreatic Cancer
Related CELG
Is More M&A On The Way For Large-Cap Biotechs?
Morgan Stanley Raises Price Target On Celgene, Still Highlights Several Risks
5 Top Stocks Riding Earnings Season To Big Gains (Investor's Business Daily)

OncoMed Pharmaceuticals (NASDAQ: OMED) rose 67.14% to $23.40 on a deal to sell 1.47 million shares to Celgene (NASDAQ: CELG) at $15.13 per share.

EnteroMedics (NASDAQ: ETRM) moved up 31.39% to $1.80 after the company announced 18 month ReCharge study results.

Conatus Pharmaceuticals (NASDAQ: CNAT) jumped 26.22% to $7.75 as the company confirmed the FDA Orphan Drug Designation for emricasan for treatment of liver transplant recipients with reestablished fibrosis.

Unilife (NASDAQ: UNIS) shares jumped 15.90% to $4.81 after the company announced clinical supply agreement with Novartis (NYSE: NVS) for delivery of a novel drug.

Posted-In: market moversNews Intraday Update Markets Movers

 

Related Articles (CELG + CNAT)

Get Benzinga's Newsletters